Filing Flows

Filing Flows › Strata Critical Medical (SRTA) › Q3 2026

Strata Critical Medical (SRTA) Q3 2026 earnings results (third quarter 2026)

10-Q filed Nov 3, 2026

Strata Critical Medical (SRTA) reported revenue of $74.1M for the third quarter 2026 (Q3 2026), +50% from a year earlier and +2% from the quarter before. Operating margin was -5.2%, net loss $7.6M (10.3% of revenue).

Revenue$74.1M
Year over year+50%
Quarter over quarter+2%
Operating margin-5.2%
Net earnings−$7.6M

Strata Critical Medical, Q3 2026: revenue $74.1M (+50% year over year), operating margin -5.2%, net loss $7.6M, operating cash flow $9.5M. The chart follows the revenue to costs, profit and cash.

Q3 2026AmountQ/QY/Y
Revenue$74.1M+2%+50%
Operating profit−$3.8M——
Net earnings−$7.6M—-113%
Operating cash flow$9.5M+66%—
Free cash flow$8.6M——

What changed

Revenue was $74.1M in Q3 2026, up 50% year over year and up 2% from the previous quarter. Logistics was the largest line at 61% of revenue. Clinical added $26.4M year over year (up 946%), 106% of the total change. Logistics declined 3%.

Gross margin was 22.7%, up 1.1 points from Q3 2025. Operating costs exceeded revenue by $3.8M, an operating margin of -5.2%. Operating expenses grew 27% against revenue growth of 50%. The fastest-growing cost line was Other operating costs (+1414%). The quarter ended with a net loss of $7.6M, narrower than the previous quarter's $10.5M loss.

Operating cash flow was $9.5M. Non-cash charges added back $7.3M of depreciation and amortization and $5.0M of share-based compensation. Working capital and other items added $4.7M. After capitalized software development costs ($415K) and purchase of property and equipment, net of proceeds from disposal ($400K), free cash flow as the company reports it was $8.6M.

Questions

What was Strata Critical Medical's revenue in the third quarter 2026?

Strata Critical Medical (SRTA) reported revenue of $74.1M for the third quarter 2026 (Q3 2026), +50% from a year earlier and +2% from the quarter before.

Was Strata Critical Medical profitable in the third quarter 2026?

Operating loss was $3.8M (-5.2% of revenue) and net loss $7.6M.

Open the interactive Sankey →

Source: Strata Critical Medical 10-Q on SEC EDGAR.